FY2029 Earnings Forecast for Calumet Issued By HC Wainwright

Calumet, Inc. (NASDAQ:CLMTFree Report) – Equities research analysts at HC Wainwright reduced their FY2029 earnings per share (EPS) estimates for Calumet in a report issued on Monday, March 2nd. HC Wainwright analyst A. Dayal now forecasts that the oil and gas company will post earnings per share of $2.48 for the year, down from their previous forecast of $2.49. HC Wainwright currently has a “Buy” rating and a $33.00 target price on the stock. The consensus estimate for Calumet’s current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet’s FY2030 earnings at $3.57 EPS.

CLMT has been the subject of several other research reports. TD Cowen reissued a “hold” rating on shares of Calumet in a research report on Thursday, January 29th. Weiss Ratings restated a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. UBS Group reaffirmed a “neutral” rating and set a $26.00 price objective on shares of Calumet in a research report on Friday, February 13th. The Goldman Sachs Group lifted their price objective on Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Finally, Zacks Research upgraded shares of Calumet from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Four research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Calumet presently has a consensus rating of “Hold” and a consensus price target of $22.83.

Read Our Latest Stock Analysis on Calumet

Calumet Stock Performance

Shares of Calumet stock opened at $29.32 on Tuesday. The company has a 50-day simple moving average of $23.56 and a two-hundred day simple moving average of $20.25. The stock has a market capitalization of $2.54 billion, a PE ratio of -75.18 and a beta of 1.18. Calumet has a 52-week low of $7.68 and a 52-week high of $30.35.

Calumet (NASDAQ:CLMTGet Free Report) last announced its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The firm had revenue of ($3,098.50) million during the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the previous year, the firm earned ($0.47) EPS. The business’s revenue for the quarter was up 9.4% on a year-over-year basis.

Institutional Investors Weigh In On Calumet

A number of large investors have recently made changes to their positions in the company. Islay Capital Management LLC bought a new position in Calumet during the fourth quarter valued at $25,000. Aster Capital Management DIFC Ltd raised its position in shares of Calumet by 294.7% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after buying an additional 1,229 shares in the last quarter. Global Retirement Partners LLC purchased a new stake in shares of Calumet during the 4th quarter valued at about $34,000. Covestor Ltd lifted its holdings in shares of Calumet by 29.1% in the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after acquiring an additional 492 shares during the last quarter. Finally, Amalgamated Bank purchased a new position in Calumet in the second quarter worth about $37,000. 34.41% of the stock is currently owned by institutional investors.

Key Calumet News

Here are the key news stories impacting Calumet this week:

  • Positive Sentiment: HC Wainwright maintains a “Buy” rating and a $33 price target on CLMT, signaling continued analyst conviction in upside to the share price despite near‑term weakness. MarketBeat: CLMT coverage
  • Positive Sentiment: HC Wainwright’s long‑run modeling is bullish: the firm projects material recovery by FY2029–FY2030 (FY2030 EPS forecast of $3.57), which can support speculative/investment interest in CLMT as a turnaround play. MarketBeat: CLMT coverage
  • Neutral Sentiment: Reported short‑interest entries for early March show anomalous/zero values (0 shares / NaN changes); the data looks unreliable and does not provide a clear signal about bearish positioning or squeeze risk. (Source: internal short‑interest entries)
  • Neutral Sentiment: Sector/industry note — TRUFUEL announced record monthly sales, reflecting strength in fuel demand for certain end markets; this is industry‑level color but not directly tied to Calumet’s corporate updates. TRUFUEL Press Release
  • Negative Sentiment: HC Wainwright sharply reduced near‑term EPS expectations: FY2026 EPS lowered to ($2.32) from ($1.22), FY2027 cut to ($0.12) from $0.23, and FY2028 trimmed to $0.98 from $1.35. Quarterly EPS forecasts for 2026 are loss‑making across Q1–Q4 per the note. These downgrades increase short‑term downside risk to profits and can weigh on valuation until visibility improves. MarketBeat: CLMT coverage

Calumet Company Profile

(Get Free Report)

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.

Featured Articles

Earnings History and Estimates for Calumet (NASDAQ:CLMT)

Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.